Reexploration and angiographic ablation for hyperparathyroidism

Area of Science:

• Endocrinology
• Surgical Oncology
• Radiology

Background:

• Persistent and recurrent hyperparathyroidism present significant clinical challenges.
• Identifying causes of initial treatment failure is crucial for effective management.

Purpose of the Study:

• Determine causes of initial hyperparathyroidism treatment failure.
• Evaluate the accuracy of preoperative localization tests.
• Assess the role and efficacy of angiographic parathyroid ablation.
• Analyze the safety and success of reexploration for hyperparathyroidism.

Main Methods:

• Retrospective review of 42 patients undergoing reexploration or angiographic ablation for hyperparathyroidism.
• Analysis of preoperative localization studies including technetium-Tc-99m-sestamibi scanning, arteriography, and venous sampling.
• Surgical reexploration via cervical or sternotomy approach.
• Angiographic ablation using catheter-guided contrast administration.

Main Results:

• Common causes of failure included mediastinal glands (18 patients) and surgeon inexperience (12 patients).
• Technetium-Tc-99m-sestamibi scanning showed 86% sensitivity for localization.
• Reexploration achieved hypercalcemia resolution in 89% (33/37) of patients.
• Angiographic ablation was successful in 67% (4/6) of patients, with no recurrent nerve injury.

Conclusions:

• Ectopic mediastinal glands and incomplete exploration are primary causes of initial hyperparathyroidism failure.
• Technetium-Tc-99m-sestamibi scans are the most sensitive preoperative localization method.
• Reexploration and angiographic ablation provide high success rates for recurrent hyperparathyroidism with acceptable risks.